Advaxis Inc (NASDAQ:ADXS)

1.89
Delayed Data
As of Feb 23
 +0.09 / +5.00%
Today’s Change
1.80
Today|||52-Week Range
10.06
-33.45%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close1.80
Today’s open1.85
Day’s range1.82 - 1.91
Volume2,163,536
Average volume (3 months)901,858
Market cap$78.5M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-11.06%
Earnings growth (this year)-6.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+201.16%
P/E ratioNM
Price/Sales11.45
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.04-0.44%
NERVMinerva Neuroscience...+0.35+6.73%
IMDZImmune Design Corp-0.02-0.76%
URGNUrogen Pharma Ltd+1.08+2.17%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMarch 12, 2018
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$12.0M
Annual profit (last year)-$93.4M
Net profit margin-776.62%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, Chief Business Officer &
Senior VP
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts